United Health Products Announces Completion of IQVIA Independent Market Assessment for HemoStyp® in Support of Review of Strategic Alternatives

NEXT STORY
Trinity Biotech Announces Results for Q1, 2019
PREV STORY
Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TLX66 Meets Study Objectives in Patients with AL Amyloidosis

Scott Litvack
Scott Litvack

Exagen Diagnostics Closes Series F Equity and Debt Raise Totaling $48 Million

ALBUQUERQUE, NM and SAN DIEGO, CA, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Exagen Diagnostics ...

author_avatar
NASDAQ Market News

Roche’s Polivy combination reduced the risk of disease worsening or death by 27% in people with previously untreated aggressive form of lymphoma

author_avatar
NASDAQ Market News